|
|
|
|
LEADER |
01651nam a22003135i 4500 |
001 |
978-1-59259-609-6 |
005 |
20190618021933.0 |
007 |
cr nn 008mamaa |
008 |
100301s1986 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781592596096
|
024 |
7 |
|
|a 10.1385/0896030784
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Receptor Binding
|c edited by Alan A. Boulton, Glen B. Baker, Pavel D. Hrdina.
|
250 |
|
|
|a 1st ed. 1986.
|
260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 1986.
|
300 |
|
|
|a XXI, 584 p. 17 illus.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Neuromethods,
|v 4
|
505 |
0 |
|
|a General Principles of Receptor Binding -- Central Nervous System Dopamine Receptors -- Adrenergic Receptors -- Serotonin Receptors -- Tryptamine and Phenylethylamine Recognition Sites in Brain -- Muscarinic Cholinergic Receptors -- Excitatory Amino Acid Receptors -- GABA Receptor Binding -- Receptors for Nonopioid Neuropeptides -- Multiple Opioid Receptors in the Central Nervous System -- Purinergic Receptors in the CNS -- The Benzodiazepine Receptor -- Binding Sites for Antidepressants -- Phencyclidine (PCP) and Amphetamine Receptor Binding Sites -- Receptor Binding in Drug Discovery and Development.
|
650 |
|
0 |
|a Neurosciences.
|
650 |
1 |
4 |
|a Neurosciences.
|
700 |
1 |
|
|a Boulton, Alan A.
|e editor.
|
700 |
1 |
|
|a Baker, Glen B.
|e editor.
|
700 |
1 |
|
|a Hrdina, Pavel D.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
856 |
4 |
0 |
|u https://doi.org/10.1385/0896030784
|